Skip to main content
SpringerLink
Log in

Multiple growth factor delivery for skin tissue engineering applications

  • Review Paper
  • Published:
Biotechnology and Bioprocess Engineering Aims and scope Submit manuscript

Abstract

Administration of exogenous growth factors (GFs) to a damaged site has been investigated for skin tissue regeneration. Among the many types of GFs and cytokines, epidermal growth factor, vascular endothelial growth factor, platelet-derived growth factor, fibroblast growth factor, and hepatocyte growth factor could be specifically used for stimulating molecules in wound healing as well as for recovery of damaged skin tissues. It is speculated that delivered GFs could stimulate various cellular functions, including proliferation, migration, deposition of extracellular matrix molecules, and remodeling of collagen synthesis. Although the physiological wound healing process is complex, engineering strategies for proper delivery of multiple therapeutic GFs could enhance the quality and quantity of regenerated skin tissues. As compared to single delivery of a GF, recent studies have proven that any combination of multiple GFs and/or therapeutic chemical factors synergistically facilitates the regeneration of damaged skin tissues. In order to maximize the stability, bioactivity, intrinsic therapeutic functionality, and efficiency of internal delivery of cargo GFs, it is essential to utilize tissueengineered biomaterials and related composites as implantable platforms. Successful fabrication and development of skin tissue engineering applications as well as subsequent surgical implantation of these platforms might provide clinical treatment for superior skin regeneration. Therefore, the present review summarizes the biological functions, related signaling mechanisms, and recent developments of tissue engineering applications for multiple GF delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fife, C. E., M. J. Cartel, D. Walker, and B. Thomson (2012) Wound care outcomes and associated cost among patients treated in us outpatient wound centers: Data from the US wound registry. Wounds 24: 10–17.

    PubMed  Google Scholar 

  2. Singer, A. J. and R. A. Clark (1999) Cutaneous wound healing. New Eng. J. Med. 341: 738–746.

    Article  CAS  PubMed  Google Scholar 

  3. Chen, F. M., M. Zhang, and Z. F. Wu (2010) Toward delivery of multiple growth factors in tissue engineering. Biomat. 31: 6279–6308.

    Article  CAS  Google Scholar 

  4. Tziotzios, C., C. Profyris, and J. Sterling (2012) Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures. J. Am. Acad. Dermatol. 66: 13–24.

    Article  CAS  PubMed  Google Scholar 

  5. Zielins, E. R., E. A. Brett, A. Luan, M. S. Hu, G. G. Walmsley, K. Paik, K. Senarath-Yapa, D. A. Atashroo, T. Wearda, H. P. Lorenz, D. C. Wan, and M. T. Longaker (2015) Emerging drugs for the treatment of wound healing. Exp. Opin. Emerg. Drugs 20: 235–246.

    Article  CAS  Google Scholar 

  6. Caussa, J. E. and E. H. Vila (2015) Epidermal growth factor, innovation and safety. Med. Clin-Barcelona 145: 305–312.

    Article  Google Scholar 

  7. Mendoza, M. C., E. E. Er, and J. Blenis (2011) The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation. Trends Biochem. Sci. 36: 320–328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bodnar, R. J. (2013) Epidermal growth factor and epidermal growth factor receptor: The yin and yang in the treatment of cutaneous wounds and cancer. Adv. Wound Care 2: 24–29.

    Article  Google Scholar 

  9. Barrientos, S., O. Stojadinovic, M. S. Golinko, H. Brem, and M. Tomic-Canic (2008) Growth factors and cytokines in wound healing. Wound Rep. Regen. 16: 585–601.

    Article  Google Scholar 

  10. Hardwicke, J., D. Schmaljohann, D. Boyce, and D. Thomas (2008) Epidermal growth factor therapy and wound healing—past, present and future perspectives. Surgeon 6: 172–177.

    Article  CAS  PubMed  Google Scholar 

  11. Xie, Y., Z. Upton, S. Richards, S. C. Rizzi, and D. I. Leavesley (2011) Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin: Growth factor complexes in wound healing applications. J. Control. Rel.: Offic. J. Control. Rel. Soc. 153: 225–232.

    Article  CAS  Google Scholar 

  12. Morell, C. M., L. Fabris, and M. Strazzabosco (2013) Vascular biology of the biliary epithelium. J. Gastroenterol. Hepatol. 28 Suppl 1: 26–32.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Patel-Hett, S. and P. A. D’Amore (2011) Signal transduction in vasculogenesis and developmental angiogenesis. Internat. J. Develop. Biol. 55: 353–363.

    Article  CAS  Google Scholar 

  14. Impellitteri, N. A., M. W. Toepke, S. K. Lan Levengood, and W. L. Murphy (2012) Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres. Biomat. 33: 3475–3484.

    Article  CAS  Google Scholar 

  15. Losi, P., E. Briganti, A. Magera, D. Spiller, C. Ristori, B. Battolla, M. Balderi, S. Kull, A. Balbarini, R. Di Stefano, and G. Soldani (2010) Tissue response to poly(ether)urethane-polydimethylsiloxanefibrin composite scaffolds for controlled delivery of proangiogenic growth factors. Biomat. 31: 5336–5344.

    Article  CAS  Google Scholar 

  16. Kazlauskas, A. (2017) PDGFs and their receptors. Gene 614: 1–7.

    Article  CAS  PubMed  Google Scholar 

  17. Ishii, Y., T. Hamashima, S. Yamamoto, and M. Sasahara (2017) Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor. Pathol. Internat. 67: 235–246.

    Article  Google Scholar 

  18. Demoulin, J. B. and A. Essaghir (2014) PDGF receptor signaling networks in normal and cancer cells. Cytokine & Growth Factor Rev. 25: 273–283.

    Article  CAS  Google Scholar 

  19. Ostendorf, T., F. Eitner, and J. Floege (2012) The PDGF family in renal fibrosis. Pediat. Nephrol. 27: 1041–1050.

    Article  PubMed  Google Scholar 

  20. Farooqi, A. A., S. Waseem, A. M. Riaz, B. A. Dilawar, S. Mukhtar, S. Minhaj, M. S. Waseem, S. Daniel, B. A. Malik, A. Nawaz, and S. Bhatti (2011) PDGF: The nuts and bolts of signalling toolbox. Tumour Biol.: The J. Internat. Soc. Oncodevelop. Biol.Med. 32: 1057–1070.

    Article  CAS  Google Scholar 

  21. Berlanga-Acosta, J., J. G. -Cowley, D. G. del Barco-Herrera, J. Martín-Machado, and G. Guillen-Nieto (2011) Epidermal Growth Factor (EGF) and Platelet-Derived Growth Factor (PDGF) as tissue healing agents: Clarifying concerns about their possible role in malignant transformation and tumor progression. J. Carcinogen. Mutagen. 2: 1000115.

    Article  CAS  Google Scholar 

  22. Judith, R., M. Nithya, C. Rose, and A. B. Mandal (2010) Application of a PDGF-containing novel gel for cutaneous wound healing. Life Sci. 87: 1–8.

    Article  CAS  PubMed  Google Scholar 

  23. Lee, J., J. J. Yoo, A. Atala, and S. J. Lee (2012) The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration. Biomat. 33: 6709–6720.

    Article  CAS  Google Scholar 

  24. Kaltalioglu, K., S. Coskun-Cevher, F. Tugcu-Demiroz, and N. Celebi (2013) PDGF supplementation alters oxidative events in wound healing process: A time course study. Arch. Dermatol. Res. 305: 415–422.

    Article  CAS  PubMed  Google Scholar 

  25. Heynen, G. J., A. Fonfara, and R. Bernards (2014) Resistance to targeted cancer drugs through hepatocyte growth factor signaling. Cell Cycle 13: 3808–3817.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Nakamura, T., K. Sakai, T. Nakamura, and K. Matsumoto (2011) Hepatocyte growth factor twenty years on: Much more than a growth factor. J. Gastroenterol. Hepatol. 26 Suppl 1: 188–202.

    Article  CAS  PubMed  Google Scholar 

  27. Molnarfi, N., M. Benkhoucha, H. Funakoshi, T. Nakamura, and P. H. Lalive (2015) Hepatocyte growth factor: A regulator of inflammation and autoimmunity. Autoimmun. Rev. 14: 293–303.

    Article  CAS  PubMed  Google Scholar 

  28. Li, J. F., H. F. Duan, C. T. Wu, D. J. Zhang, Y. Deng, H. L. Yin, B. Han, H. C. Gong, H. W. Wang, and Y. L. Wang (2013) HGF accelerates wound healing by promoting the dedifferentiation of epidermal cells through beta1-integrin/ILK pathway. BioMed Res. Internat. 2013: 470418.

    Google Scholar 

  29. Baek, J. H., C. Birchmeier, M. Zenke, and T. Hieronymus (2012) The HGF receptor/Met tyrosine kinase is a key regulator of dendritic cell migration in skin immunity. J. Immunol. 189: 1699–1707.

    Article  CAS  PubMed  Google Scholar 

  30. Hubel, J. and T. Hieronymus (2015) HGF/Met-signaling contributes to immune regulation by modulating tolerogenic and motogenic properties of dendritic cells. Biomed. 3: 138–148.

    Google Scholar 

  31. Rah, D. K., I. S. Yun, C. O. Yun, S. B. Lee, and W. J. Lee (2014) Gene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model. J. Kor. Med. Sci. 29 Suppl 3: S228–236.

    Article  CAS  Google Scholar 

  32. Yun, Y. R., J. E. Won, E. Jeon, S. Lee, W. Kang, H. Jo, J. H. Jang, U. S. Shin, and H. W. Kim (2010) Fibroblast growth factors: Biology, function, and application for tissue regeneration. J. Tissue Eng. 2010: 218142.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ornitz, D. M. and N. Itoh (2015) The fibroblast growth factor signaling pathway. Wiley Interdiscipl. Rev. Develop. Biol. 4: 215–266.

    Article  CAS  Google Scholar 

  34. Singla, D. K., R. D. Singla, L. S. Abdelli, and C. Glass (2015) Fibroblast growth factor-9 enhances M2 macrophage differentiation and attenuates adverse cardiac remodeling in the infarcted diabetic heart. PloS one 10: e0120739.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Zhang, H. Y., X. Zhang, Z. G. Wang, H. X. Shi, F. Z. Wu, B. B. Lin, X. L. Xu, X. J. Wang, X. B. Fu, Z. Y. Li, C. J. Shen, X. K. Li, and J. Xiao (2013) Exogenous basic fibroblast growth factor inhibits ER stress-induced apoptosis and improves recovery from spinal cord injury. CNS Neurosci. Therap. 19: 20–29.

    Article  CAS  Google Scholar 

  36. Hankenson, K. D., K. Gagne, and M. Shaughnessy (2015) Extracellular signaling molecules to promote fracture healing and bone regeneration. Adv. Drug Del. Rev. 94: 3–12.

    Article  CAS  Google Scholar 

  37. De Smet, F., B. Tembuyser, A. Lenard, F. Claes, J. Zhang, C. Michielsen, A. Van Schepdael, J. M. Herbert, F. Bono, M. Affolter, M. Dewerchin, and P. Carmeliet (2014) Fibroblast growth factor signaling affects vascular outgrowth and is required for the maintenance of blood vessel integrity. Chem. Biol. 21: 1310–1317.

    Article  CAS  PubMed  Google Scholar 

  38. Falcon, B. L., M. Swearingen, W. H. Gough, L. Lee, R. Foreman, M. Uhlik, J. C. Hanson, J. A. Lee, D. B. McClure, and S. Chintharlapalli (2014) An in vitro cord formation assay identifies unique vascular phenotypes associated with angiogenic growth factors. PloS one 9: e106901.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Takikawa, M., S. Nakamura, M. Ishihara, Y. Takabayashi, M. Fujita, H. Hattori, T. Kushibiki, and M. Ishihara (2015) Improved angiogenesis and healing in crush syndrome by fibroblast growth factor-2-containing low-molecular-weight heparin (Fragmin)/ protamine nanoparticles. J. Surg. Res. 196: 247–257.

    Article  CAS  PubMed  Google Scholar 

  40. Xie, L., M. Zhang, B. Dong, M. Guan, M. Lu, Z. Huang, H. Gao, and X. Li (2011) Improved refractory wound healing with administration of acidic fibroblast growth factor in diabetic rats. Diabetes Res. Clin. Pract. 93: 396–403.

    Article  CAS  PubMed  Google Scholar 

  41. Matsumoto, S., R. Tanaka, K. Okada, K. Arita, H. Hyakusoku, M. Miyamoto, Y. Tabata, and H. Mizuno (2013) The Effect of Control-released basic fibroblast growth factor in wound healing: Histological analyses and clinical application. Plast. Reconstr. Surg. Global Open 1: e44.

    Article  Google Scholar 

  42. Nakamizo, S., G. Egawa, H. Doi, Y. Natsuaki, Y. Miyachi, and K. Kabashima (2013) Topical treatment with basic fibroblast growth factor promotes wound healing and barrier recovery induced by skin abrasion. Skin Pharmacol. Physiol. 26: 22–29.

    Article  CAS  PubMed  Google Scholar 

  43. Fuhr, M. J., M. Meyer, E. Fehr, G. Ponzio, S. Werner, and H. J. Herrmann (2015) A modeling approach to study the effect of cell polarization on keratinocyte migration. PloS one 10: e0117676.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Peplow, P. V. and M. P. Chatterjee (2013) A review of the influence of growth factors and cytokines in in vitro human keratinocyte migration. Cytokine 62: 1–21.

    Article  CAS  PubMed  Google Scholar 

  45. Akita, S., K. Akino, and A. Hirano (2013) Basic fibroblast growth factor in scarless wound healing. Adv. Wound Care 2: 44–49.

    Article  Google Scholar 

  46. Shi, H. X., C. Lin, B. B. Lin, Z. G. Wang, H. Y. Zhang, F. Z. Wu, Y. Cheng, L. J. Xiang, D. J. Guo, X. Luo, G. Y. Zhang, X. B. Fu, S. Bellusci, X. K. Li, and J. Xiao (2013) The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo. PloS one 8: e59966.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Abe, M., Y. Yokoyama, and O. Ishikawa (2012) A possible mechanism of basic fibroblast growth factor-promoted scarless wound healing: The induction of myofibroblast apoptosis. Europ. J. Dermatol. 22: 46–53.

    CAS  Google Scholar 

  48. Mirdailami, O., M. Soleimani, R. Dinarvand, M. R. Khoshayand, M. Norouzi, A. Hajarizadeh, M. Dodel, and F. Atyabi (2015) Controlled release of rhEGF and rhbFGF from electrospun scaffolds for skin regeneration. J. Biomed. Mat. Res. Part A. 103: 3374–3385.

    Article  CAS  Google Scholar 

  49. Choi, J. S., S. H. Choi, and H. S. Yoo (2011) Coaxial electrospun nanofibers for treatment of diabetic ulcers with binary release of multiple growth factors. J. Mater. Chem. 21: 5258–5267.

    Article  CAS  Google Scholar 

  50. Lai, H. J., C. H. Kuan, H. C. Wu, J. C. Tsai, T. M. Chen, D. J. Hsieh, and T. W. Wang (2014) Tailored design of electrospun composite nanofibers with staged release of multiple angiogenic growth factors for chronic wound healing. Acta Biomat. 10: 4156–4166.

    Article  CAS  Google Scholar 

  51. Ribeiro, M. P., P. I. Morgado, S. P. Miguel, P. Coutinho, and I. J. Correia (2013) Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing. Mat. Sci. Eng. C-Mater. 33: 2958–2966.

    Article  CAS  Google Scholar 

  52. Yang, D. H., D. I. Seo, D. W. Lee, S. H. Bhang, K. Park, G. Jang, C. H. Kim, and H. J. Chun (2017) Preparation and evaluation of visible-light cured glycol chitosan hydrogel dressing containing dual growth factors for accelerated wound healing. J. Ind. Eng. Chem. 53: 360–370.

    Article  CAS  Google Scholar 

  53. Goel, A., A. B. Kunnumakkara, and B. B. Aggarwal (2008) Curcumin as “Curecumin”: From kitchen to clinic. Biochem. Pharmacol. 75: 787–809.

    Article  CAS  PubMed  Google Scholar 

  54. Cheppudira, B., M. Fowler, L. McGhee, A. Greer, A. Mares, L. Petz, D. Devore, D. R. Loyd, and J. L. Clifford (2013) Curcumin: A novel therapeutic for burn pain and wound healing. Expert Opin. Investigat. Drugs 22: 1295–1303.

    Article  CAS  Google Scholar 

  55. Li, X., X. Ye, J. Qi, R. Fan, X. Gao, Y. Wu, L. Zhou, A. Tong, and G. Guo (2016) EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent. Internat. J. Nanomed. 11: 3993–4009.

    Article  CAS  Google Scholar 

  56. Xie, Z., C. B. Paras, H. Weng, P. Punnakitikashem, L. C. Su, K. Vu, L. Tang, J. Yang, and K. T. Nguyen (2013) Dual growth factor releasing multi-functional nanofibers for wound healing. Acta Biomat. 9: 9351–9359.

    Article  CAS  Google Scholar 

  57. Losi, P., E. Briganti, C. Errico, A. Lisella, E. Sanguinetti, F. Chiellini, and G. Soldani (2013) Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice. Acta Biomat. 9: 7814–7821.

    Article  CAS  Google Scholar 

  58. Hollier, B., D. G. Harkin, D. Leavesley, and Z. Upton (2005) Responses of keratinocytes to substrate-bound vitronectin: Growth factor complexes. Experim. Cell Res. 305: 221–232.

    Article  CAS  Google Scholar 

  59. Ogino, S., N. Morimoto, M. Sakamoto, C. Jinno, Y. Sakamoto, T. Taira, and S. Suzuki (2018) Efficacy of the dual controlled release of HGF and bFGF impregnated with a collagen/gelatin scaffold. J. Surg. Res. 221: 173–182.

    Article  CAS  PubMed  Google Scholar 

  60. Kiso, M., T. S. Hamazaki, M. Itoh, S. Kikuchi, H. Nakagawa, and H. Okochi (2015) Synergistic effect of PDGF and FGF2 for cell proliferation and hair inductive activity in murine vibrissal dermal papilla in vitro. J. Dermatol. Sci. 79: 110–118.

    Article  CAS  PubMed  Google Scholar 

  61. Shi, J., J. Li, H. Guan, W. Cai, X. Bai, X. Fang, X. Hu, Y. Wang, H. Wang, Z. Zheng, L. Su, D. Hu, and X. Zhu (2014) Antifibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scarforming fibroblasts. PloS one 9: e98228.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. So, K., D. A. McGrouther, J. A. Bush, P. Durani, L. Taylor, G. Skotny, T. Mason, A. Metcalfe, S. O'Kane, and M. W. Ferguson (2011) Avotermin for scar improvement following scar revision surgery: A randomized, double-blind, within-patient, placebocontrolled, phase II clinical trial. Plast. Reconstr. Surg. 128: 163–172.

    Article  CAS  PubMed  Google Scholar 

  63. Kieran, I., A. Knock, J. Bush, K. So, A. Metcalfe, R. Hobson, T. Mason, S. O’Kane, and M. Ferguson (2013) Interleukin-10 reduces scar formation in both animal and human cutaneous wounds: Results of two preclinical and phase II randomized control studies. Wound Rep.Regen. 21: 428–436.

    Article  Google Scholar 

  64. Shi, J. H., H. Guan, S. Shi, W. X. Cai, X. Z. Bai, X. L. Hu, X. B. Fang, J. Q. Liu, K. Tao, X. X. Zhu, C. W. Tang, and D. H. Hu (2013) Protection against TGF-beta 1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring. Arch. Dermatol. Res. 305: 341–352.

    Article  CAS  PubMed  Google Scholar 

  65. Lee, M. S., T. Ahmad, J. Lee, H. K. Awada, Y. Wang, K. Kim, H. Shin, and H. S. Yang (2017) Dual delivery of growth factors with coacervate-coated poly(lactic-co-glycolic acid) nanofiber improves neovascularization in a mouse skin flap model. Biomat. 124: 65–77.

    Article  CAS  Google Scholar 

  66. Finnson, K. W., S. McLean, G. M. Di Guglielmo, and A. Philip (2013) Dynamics of transforming growth factor beta signaling in wound healing and scarring. Adv. Wound Care 2: 195–214.

    Article  Google Scholar 

  67. Arno, A. I., G. G. Gauglitz, J. P. Barret, and M. G. Jeschke (2014) New molecular medicine-based scar management strategies. Burns 40: 539–551.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Chen, W. C., B. G. Lee, D. W. Park, K. Kim, H. Chu, K. Kim, J. Huard, and Y. Wang (2015) Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair. Biomater. 72: 138–151.

    Article  CAS  Google Scholar 

  69. Kim, K., W. C. W. Chen, Y. Heo, and Y. D. Wang (2016) Polycations and their biomedical applications. Prog. Polym. Sci. 60: 18–50.

    Article  CAS  Google Scholar 

  70. Shin, S., J. U. Shin, Y. Lee, W. Y. Chung, K. H. Nam, T. G. Kwon, and J. H. Lee (2017) The effects of multi-growth factorscontaining cream on post-thyroidectomy Scars: A preliminary study. Ann. Dermatol. 29: 314–320.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Satish, L. (2015) Chemokines as therapeutic targets to improve healing efficiency of chronic wounds. Adv. Wound Care 4: 651–659.

    Article  Google Scholar 

  72. Laiva, A. L., F. J. O'Brien, and M. B. Keogh (2017) Innovations in gene and growth factor delivery systems for diabetic wound healing. J. Tissue Eng. Regen. Med. doi: 10.1002/term.2443.

    Google Scholar 

  73. Pereira, R. F., C. C. Barrias, P. L. Granja, and P. J. Bartolo (2013) Advanced biofabrication strategies for skin regeneration and repair. Nanomed. 8: 603–621.

    Article  CAS  Google Scholar 

  74. Zamani, M., M. P. Prabhakaran, and S. Ramakrishna (2013) Advances in drug delivery via electrospun and electrosprayed nanomaterials. Internat. J. Nanomed. 8: 2997–3017.

    Google Scholar 

  75. Liu, W., X. Wu, and Z. Gao (2011) New potential antiscarring approaches. Wound Rep. Regen. 19 Suppl 1: s22–31.

    Article  Google Scholar 

  76. Gauglitz, G. G., H. C. Korting, T. Pavicic, T. Ruzicka, and M. G. Jeschke (2011) Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol. Med. 17: 113–125.

    Article  CAS  PubMed  Google Scholar 

  77. Ibrahim, M. M., J. Bond, A. Bergeron, K. J. Miller, T. Ehanire, C. Quiles, E. R. Lorden, M. A. Medina, M. Fisher, B. Klitzman, M. A. Selim, K. W. Leong, and H. Levinson (2014) A novel immune competent murine hypertrophic scar contracture model: A tool to elucidate disease mechanism and develop new therapies. Wound Rep. Regen. 22: 755–764.

    Article  Google Scholar 

  78. Van Den Broek, L. J., F. B. Niessen, R. J. Scheper, and S. Gibbs (2012) Development, validation and testing of a human tissue engineered hypertrophic scar model. ALTEX 29: 389–402.

    Article  PubMed  Google Scholar 

  79. Hartwell, R., M. S. Poormasjedi-Meibod, C. Chavez-Munoz, R. B. Jalili, A. Hossenini-Tabatabaei, and A. Ghahary (2015) An insitu forming skin substitute improves healing outcome in a hypertrophic scar model. Tissue Eng. Part A. 21: 1085–1094.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Bioengineering, College of Life Sciences and Bioengineering, Incheon National University, Incheon, 22012, Korea

    Uiseon Park & Kyobum Kim

Authors
  1. Uiseon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyobum Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kyobum Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, U., Kim, K. Multiple growth factor delivery for skin tissue engineering applications. Biotechnol Bioproc E 22, 659–670 (2017). https://doi.org/10.1007/s12257-017-0436-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12257-017-0436-1

Keywords

Search

Navigation